GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oramed Pharmaceuticals Inc (XTAE:ORMP) » Definitions » Cyclically Adjusted Book per Share

Oramed Pharmaceuticals (XTAE:ORMP) Cyclically Adjusted Book per Share : ₪9.83 (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Oramed Pharmaceuticals Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Oramed Pharmaceuticals's adjusted book value per share for the three months ended in Mar. 2024 was ₪15.046. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₪9.83 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Oramed Pharmaceuticals's average Cyclically Adjusted Book Growth Rate was 13.50% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 21.50% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 16.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Oramed Pharmaceuticals was 21.50% per year. The lowest was 8.30% per year. And the median was 15.40% per year.

As of today (2024-05-26), Oramed Pharmaceuticals's current stock price is ₪8.552. Oramed Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was ₪9.83. Oramed Pharmaceuticals's Cyclically Adjusted PB Ratio of today is 0.87.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Oramed Pharmaceuticals was 16.95. The lowest was 0.70. And the median was 3.78.


Oramed Pharmaceuticals Cyclically Adjusted Book per Share Historical Data

The historical data trend for Oramed Pharmaceuticals's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oramed Pharmaceuticals Cyclically Adjusted Book per Share Chart

Oramed Pharmaceuticals Annual Data
Trend Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.82 4.78 5.44 7.29 9.30

Oramed Pharmaceuticals Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.53 9.36 9.47 9.30 9.83

Competitive Comparison of Oramed Pharmaceuticals's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Oramed Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oramed Pharmaceuticals's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oramed Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Oramed Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.



Oramed Pharmaceuticals Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Oramed Pharmaceuticals's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=15.046/131.7762*131.7762
=15.046

Current CPI (Mar. 2024) = 131.7762.

Oramed Pharmaceuticals Quarterly Data

Book Value per Share CPI Adj_Book
201405 8.074 100.373 10.600
201408 7.530 100.352 9.888
201411 8.018 99.635 10.605
201502 7.553 99.032 10.050
201505 7.200 100.333 9.456
201508 7.856 100.548 10.296
201511 7.108 100.135 9.354
201602 9.127 100.040 12.022
201605 8.633 101.355 11.224
201608 7.268 101.617 9.425
201611 6.614 101.829 8.559
201702 5.869 102.779 7.525
201705 5.441 103.256 6.944
201708 5.149 103.587 6.550
201711 5.815 104.072 7.363
201802 5.201 105.052 6.524
201805 4.212 106.148 5.229
201808 6.553 106.383 8.117
201811 6.075 106.338 7.528
201902 5.336 106.649 6.593
201905 4.537 108.048 5.533
201908 4.082 108.245 4.969
201911 3.608 108.519 4.381
202002 2.549 109.139 3.078
202005 5.362 108.175 6.532
202008 5.081 109.662 6.106
202011 4.335 109.793 5.203
202102 6.394 110.968 7.593
202105 8.165 113.576 9.473
202108 12.001 115.421 13.702
202111 16.345 117.269 18.367
202203 15.402 121.301 16.732
202206 14.581 125.017 15.369
202209 14.387 125.227 15.139
202212 14.038 125.222 14.773
202303 13.819 127.348 14.300
202306 13.785 128.729 14.111
202309 13.545 129.860 13.745
202312 14.858 129.419 15.129
202403 15.046 131.776 15.046

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Oramed Pharmaceuticals  (XTAE:ORMP) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Oramed Pharmaceuticals's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=8.552/9.83
=0.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Oramed Pharmaceuticals was 16.95. The lowest was 0.70. And the median was 3.78.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Oramed Pharmaceuticals Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Oramed Pharmaceuticals's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Oramed Pharmaceuticals (XTAE:ORMP) Business Description

Comparable Companies
Traded in Other Exchanges
Address
1185 Avenue of the Americas, Third Floor, New York, NY, USA, 10036
Oramed Pharmaceuticals Inc is a pharmaceutical company which is engaged in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The ORMD-0801 is a proprietary product which is an orally ingestible insulin capsule for the treatment of diabetes. Its other product includes Oral Glucagon-like peptide-1 which is an incretin hormone, a type of gastrointestinal hormone that stimulates the secretion of insulin from the pancreas.